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Purpose: This study aimed to examine the effectiveness of CO2 laser-assisted sclerectomy surgery (CLASS) in eyes
with primary open-angle glaucoma (POAG) showing progression in spite of maximal local antiglaucomatous therapy.
Materials and methods: Patients with progressive POAG received CLASS treatment. We performed CLASS on 15 eyes
(eight males and seven females). The primary endpoint was the change in the intraocular pressure (IOP), and
additionally best spectacle-corrected visual acuity (BSCVA), C/D ratio (cup-to-disc), as well as use of antiglaucomatous
drops were also investigated. Following the preoperative assessment, measurements were performed at 6-month follow-
up. Results: The average preoperative IOP was 26.13± 6.79 mmHg that dropped to 9.57± 4.09 mmHg at 1 day. IOP
was stable at 1 month, 3 months, and 6 months. The BSCVA decreased to the 1-day and 1-week follow-up but returned
to its original value to the 1-month check-up. Preoperatively, all patients were on maximal antiglaucoma drop therapy,
after CLASS none of the patients needed antiglaucomatous treatment at 1 month. However, at 3 months, one of them
needed antiglaucoma drops. C/D ratio showed non-significant changes. Conclusions: CLASS procedure was found to
be effective in decreasing IOP in POAG patients whose IOP was not compensated with maximal antiglaucomatous local
therapy; patients needed significantly less local therapy following the CO2 laser surgery.
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INTRODUCTION
Primary open-angle glaucoma (POAG) is a progressive,
chronic disease, which is characterised by gradual in-
crease of the intraocular pressure (IOP) and damage of
the small arterioles of the optic nerve, with a consecutive
imbalance between IOP and circulation of the optic nerve
head. Consequently, the ophthalmologist may observe
cupping of the optic nerve head together with visual field
defect.
Undiagnosed POAG is relatively frequent in the Cauca-
sian population and the disease may remain hidden until
significant visual field defect. The problem is that this defect
is irreversible; therefore, early diagnosis and efficient treat-
ments have utmost importance halting the visual field
deterioration and protecting visual acuity.
The cause of POAG is multifactorial with family history
certainly playing an important role in it. Usually, the resis-
tance of the trabecular meshwork is increased; therefore, the
aqueous humour produced by the ciliary processes cannot
leave the eye properly through the trabecular meshwork and
consequently the IOP increases. The increase is usually
gradual and affects the two eyes differently, so sometimes
the patient does not notice it, because they do not test their
eyes (the visual acuity and visual field) with separate eyes.
Conservative therapy means using eye drops in order to
decrease the IOP. Several eyedrops are available in Europe,
but in some patients conservative therapy cannot decrease
IOP below abnormal values (usually below 21 mmHg) even
with maximal therapy. For these patients, surgery is needed.
Before antiglaucomatous eyedrops, trabeculectomy was the
most frequently performed IOP-lowering surgical interven-
tion, although there were several side effects, including
postoperative hypotony, choroidal detachment, suprachor-
oidal bleeding, endophthalmitis, malignant glaucoma, and
cataract [1]. Therefore, non-penetrating glaucoma surgery
came into focus a decade ago [2].
Performing non-penetrating surgery manually is chal-
lenging and difficult, and sometimes around the last step of
the surgery, the thin sclera perforates and the surgery is
transformed into a penetrating procedure with the all possi-
ble side effects.
Manual deep sclerectomy, according to the data pub-
lished in literature [2–5], results in less reduction of IOP,
and similarly the side effects are also significantly milder.
The reason is that the trabeculo-Descemet membrane stays
intact, so the decrease of IOP is more gradual in these
patients.
Because manual non-penetrating glaucoma surgery is
difficult, CO2 laser has been introduced to standardise the
method and to increase predictability and safety. The new
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technique was first introduced and published by Assia et al.
[6]. Several technical modifications have been made since
the first prototype, and by now the CO2 laser is available
commercially [3, 4, 7]. In this article, we present the first
clinical results with CO2 laser-assisted sclerectomy surgery
(CLASS).
MATERIALS AND METHODS
CLASS procedure was performed in 15 POAG eyes in the
Department of Ophthalmology, Semmelweis University,
Budapest, Hungary. Patients with progressive POAG glau-
coma received CLASS treatment on the worse eye. Fifteen
eyes of 14 patients were enrolled into the study. The average
age of the patients was 62.97 ± 11.81 years. Among them,
eight were males and seven were females. During preopera-
tive assessment, medical and family histories were recorded,
IOP, as well as uncorrected and best spectacle-corrected
visual acuity (UCVA and BSCVA) were determined, and
C/D ratio was documented. Similar measurements were
performed during the follow-up visits at 1 day, 1 week,
1 month, 3 months, and 6 months postoperatively.
Surgical method
Most of the surgeries were performed under retrobulbar
anesthesia, but in four cases, with less compliant patients,
general anesthesia was applied. Fornix-based conjunctival
flap was created at the beginning of the surgery, then a
limbus-based 5 × 5 mm scleral flap was made with a special
single-use crescent knife (scleral flap was 1 × 1 mm larger
than in normal trabeculectomy procedures). Afterwards, flap
preparation of 0.02% mitomycin-C (MMC) soaked using
small sponges was tucked between the conjunctiva and the
scleral flap for 2 min. Then, the MMC was washed out
and the CO2 laser was applied (IOPtima Ltd., Ramat-Gan,
Israel). During the laser procedure, at first, a 4.0 × 1.6 mm
aqueous reservoir was created, then around the Schlemm-
channel, another 4.0 × 1.0 mm semiperforating scleral pool
was created by the laser in a crescent-shaped form.
When bubble formation in the aqueous humour occurred,
CO2 laser treatment was finished. The corners of the scleral
flap were sutured with 10/0 nylon sutures and then the
conjunctiva was also sutured with the 10/0 nylon, especially
at the edges. At the end of the surgery, subconjunctival
dexamethasone was administered.
Patients were examined at 1 day, 1 week, 1 month, 3
months, and 6 months. If it was necessary, the conjunctival
flap was checked more frequently (every week during the
first postoperative month, then according to the protocol).
UCVA and BSCVA were tested, IOP was measured by
Goldmann tonometry, C/D ratio was determined, and the
necessary antiglaucomatous drops were registered in the
patient’s file. Intraoperative and postoperative complica-
tions were also recorded and later analysed.
Statistical analysis was performed using the IBM SPSS
Statistics for Windows v21 (IBM Corp., Released 2012,
Armonk, NY, USA). Preoperative and postoperative IOP
values and visual acuity results were compared with paired
t-test.
RESULTS
The average preoperative IOP was 26.13± 6.79 mmHg.
Following the surgery, the IOP dropped already at Day 1 to
9.57± 4.09 mmHg (p< .001). The postoperative IOP was
stable and significantly lower following the CLASS proce-
dures (p< .05) than the preoperative values on each follow-
up visit (1 week, 1 month, 3 months, and 6 months;
Figure 1). With regard to IOP, there was no significant
difference between the result of the 6-month follow-up.
BSCVA decreased significantly on the first day follow-
ing the surgery (p= .017), improved significantly by the
1-week check-up (p= .039), and returned to the original
value at the 1-month visit (p< .001). During the follow-up
period, there was no significant difference between the pre-
and postoperative BSCVA results 1 week after the surgery
(p> .05; Figure 2)
The preoperative C/D ratio was 0.84± 0.17, with no
significant change during the follow-up period (p> .05).
Figure 1. Changes of intraocular pressure (IOP) due to CLASS
procedure
Figure 2. Changes of best-corrected visual acuity (BSCVA) due to
CLASS procedure
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Preoperatively, all patients were on antiglaucomatous
drop therapy, most of them using two or more types of
drops. One patient was consuming oral acetazolamide
(250 mg) pills; after CLASS procedure, they did not
need it anymore. None of the patients needed antiglau-
comatous treatment at 1 month; however, at 3 months,
three of them needed one type of drop therapy. During the
first month, one of the patients showed an IOP higher
than 18 mmHg. Therefore, the decrease of drop therapy
was significantly smaller compared to preoperative anti-
glaucoma drop use.
Among the patients, two had inadvertent scleral pene-
tration during surgery; therefore, one case was converted
into trabeculectomy and the other had a small injury of the
ciliary body. No hyphaema or hypotony was experienced
in these two cases, and IOP stayed within normal range
during the whole follow-up period. On the other hand, in
another patient, a transient choroidal detachment was
found during the early postoperative period with lower
IOP. This was resolved within 3 weeks and the IOP was
in normal range (below 18 mmHg). In three cases, con-
junctival vessel dilation and tortuosity were found without
IOP rise.
DISCUSSION
The IOP decreasing effect is smaller in case of non-
penetrating glaucoma surgery, including the CLASS proce-
dure as well, although severe postoperative complications
are also much less common compared to filtration proce-
dures [1, 5]. Due to the milder IOP decrease, the danger of
abrupt visual field loss is also rare, which can be experi-
enced in advanced glaucoma cases following filtrating
surgery, such as trabeculectomy.
CLASS offers a reasonable solution for the technical
problems of manual non-penetrating surgeries as well,
because this is a titratable method, the juxtacanalicular
trabecular meshwork can be opened without a real perfo-
ration [3, 4, 7]. The aqueous humour appearing in the
ablated area prevents further laser tissue destruction. When
the underlying sclera is very thin, inadvertent scleral
perforation may occur; however, with meticulous scleral
flap preparation (not too thick), this complication can be
avoided. In one case, we could not explain the cause of
choroidal detachment, because there was no complete
scleral perforation and the scleral flap was also not too
thick. The CO2 laser is able to deliver even and planned
size of tissue ablation; the surrounding tissue the thermal
damage was minimal.
Using the MMC sponge, the chance of scarring, tissue
fibrosis, and adhesion are significantly smaller.
In POAG cases with CLASS procedure in the literature,
different results are published, in which some of the authors
achieved a 45.1%, others only 19.0% decrease of IOP
during the 6-month follow-up period [3, 4, 7].
Among our patients, IOP decrease was significant
in patients who were on maximal antiglaucomatous
topical therapy and showing glaucoma progression.
Importantly, IOP stayed in the normal range; BSCVA did
not decrease statistically in a significant way. During the
first postoperative month, none of the patients needed
antiglaucoma therapy, at months 3 and 6; three patients
needed extra eye pressure-lowering drops (but only one
type of drop).
Based on our results, the CLASS procedure was found to
be effective and efficient in decreasing IOP in patients
whose IOP was not compensated with maximal antiglau-
comatous local therapy, and patients needed significantly
less local therapy following the CO2 laser surgery.
CONCLUSIONS
We recommend the method in case of POAG. Possibly, the
CLASS procedure can be applied in earlier glaucoma cases
also to prevent serious progression and visual field deterio-
ration. Nevertheless, we find it necessary to include a larger
patient group with longer follow-up period to find out the
real efficiency of the method.
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